StonvexLoading…
StonvexStonvexStonvexCore line items from CAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $65.65B | $129.64B | $64.01B | $222.58B | $162.42B |
Operating Income | Not available | $1.38B | $668.00M | $2.27B | $1.85B |
Net Income | Not available | $917.00M | $450.00M | $1.56B | $1.32B |
EPS (Diluted) | $2.43 | $3.85 | $1.88 | $6.45 | $5.44 |
Total Assets | Not available | $58.08B | $55.23B | $53.12B | $49.87B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $2.78B | $4.59B | $3.87B | $3.33B |
Free Cash Flow OCF − CapEx | Not available | $1.42B | $865.00M | $1.85B | $555.00M |
Shares Outstanding | Not available | 238.00M | 239.00M | 242.00M | 243.00M |